Scarica l'app Stockscreener
121.73
0.11%
-0.135
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$121.87
Aprire:
$122.42
Volume 24 ore:
950.58K
Relative Volume:
1.21
Capitalizzazione di mercato:
$6.84B
Reddito:
$633.51M
Utile/perdita netta:
$-8.10M
Rapporto P/E:
-392.69
EPS:
-0.31
Flusso di cassa netto:
$131.26M
1 W Prestazione:
+4.72%
1M Prestazione:
-1.84%
6M Prestazione:
-26.62%
1 anno Prestazione:
-8.03%
Intervallo 1D:
$120.67
$123.14
Intervallo di 1 settimana:
$110.85
$123.14
Portata 52W:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Confronta RGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
121.73 | 6.85B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
495.86 | 175.16B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
185.32 | 52.63B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
91.86 | 45.46B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
275.16 | 40.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
263.51 | 20.05B | 2.90B | 467.20M | 306.90M | 6.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
What drives Repligen Corporation stock priceFree Predictions - Autocar Professional
What institutions are buying Repligen Corporation stock nowExceptional profit margins - jammulinksnews.com
Repligen Corporation (NASDAQ:RGEN) Shares Purchased by Signaturefd LLC - Defense World
Repligen’s 39% decline validates InvestingPro’s January 2024 bearish call By Investing.com - Investing.com
Repligen (RGEN) Receives Overweight Rating with $160 Price Targe - GuruFocus
Here's Why Repligen (RGEN) is a Strong Growth Stock - Yahoo Finance
Repligen FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World
What analysts say about Repligen Corporation stockExplosive portfolio gains - PrintWeekIndia
Envestnet Asset Management Inc. Reduces Position in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corp to Release Q2 2025 Financial Results and Host Conference Call on July 29, 2025. - AInvest
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
M&T Bank Corp Reduces Stake in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen to Report Second Quarter 2025 Financial Results - The Globe and Mail
Repligen Corporation to Announce Second Quarter 2025 Financial Results on July 29 - Quiver Quantitative
How KEY.PRK stock performs during market volatilityFree Consultation - Newser
Why DOCU stock attracts strong analyst attentionHigh Potential Shares - Newser
How Life360 Inc. stock performs during market volatilityFree Stock Market Knowledge Sharing - Newser
Protein Purification and Isolation Market Size to Surpass USD 33.02 Billion by 2034 - BioSpace
Parnassus Mid Cap Growth Fund Q2 2025 Commentary - Seeking Alpha
Parnassus Mid Cap Fund Q2 2025 Commentary - Seeking Alpha
Why Repligen Corporation stock attracts strong analyst attentionInstant Stock Updates - Newser
What makes ScanSource Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes HUTCHMED (China) Limited Depositary Receipt stock price move sharplyFree Join Group - Newser
How Repligen Corporation stock performs during market volatility200 Percent Profit Outlook - Newser
Why Sphere 3D Corp. stock attracts strong analyst attentionFree Stock Trading Community - Newser
Why ROAD stock attracts strong analyst attentionTop Analyst Picks - Newser
Evercore ISI Cuts Repligen (NASDAQ:RGEN) Price Target to $130.00 - Defense World
Repligen And 2 Other Stocks That May Be Trading Below Estimated Value - Yahoo Finance
GAMMA Investing LLC Boosts Holdings in Repligen Corporation (NASDAQ:RGEN) - Defense World
Repligen Corporation (NASDAQ:RGEN) Shares Purchased by KBC Group NV - Defense World
Fluor Corporation (NYSE:FLR) Shares Sold by Amalgamated Bank - Defense World
Wall Street Zen Downgrades Repligen (NASDAQ:RGEN) to Hold - Defense World
Improving Process Reliability in mAb Manufacturing - Genetic Engineering and Biotechnology News
Barclays Initiates Coverage on Repligen (RGEN) with Positive Out - GuruFocus
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Three Stocks That May Be Trading Below Their Intrinsic Value In June 2025 - Yahoo Finance
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada
Repligen at William Blair Conference: Innovation Drives Growth - Investing.com
Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance
Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
5.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):